Acumen Pharmaceuticals, Inc. (ABOS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Acumen Pharmaceuticals, Inc. (ABOS)
Go deeper and ask any question about ABOS
Company Performance
Current Price
as of Sep 13, 2024$2.60
P/E Ratio
N/A
Market Cap
$156.21M
Description
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Metrics
Overview
- HQCharlottesville, VA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerABOS
- Price$2.6+6.12%
Trading Information
- Market Cap$156.21M
- Float74.95%
- Average Daily Volume (1m)173,636
- Average Daily Volume (3m)402,153
- EPS-$1.11
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$20.54M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$24.34M
- EV-$85.35M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset